Literature DB >> 17409772

Age and risk of stroke in atrial fibrillation: evidence for guidelines?

Lars Frost1, Ljubica Vukelic Andersen, John Godtfredsen, Leif Spange Mortensen.   

Abstract

AIM: Guidelines for the clinical management of patients with atrial fibrillation suggest that treatment strategies for prescribing oral anticoagulant therapy should implicate change at age 60, 65 and 75 years. We examined if there is any threshold concerning risk of stroke by age.
METHODS: We identified 141,493 subjects, aged 40-89 years, with an incident hospital diagnosis of nonvalvular atrial fibrillation or flutter and no previous or concomitant diagnosis of stroke in the Danish National Registry of Patients from January 1, 1980, to December 31, 2002. The subjects were followed in the Danish National Registry of Patients for the occurrence of an incident diagnosis of stroke of any nature and in the Danish Civil Registration System for emigration and vital status. We examined the risk of stroke by age in men and women using Cox regression models, which included age categorized in intervals, linear splines of age with cut points at age 60 and 75 years, or at age 65 and 75 years. We also analyzed age as a continuous variable in linear and polynomial regression models.
RESULTS: During follow-up 15,964 incident strokes were reported to the Danish National Registry of Patients. The risk of stroke increased by increasing age at baseline. We did not find any evidence for a threshold concerning risk of stroke by age, and the best model fit was obtained in a third-order polynomial regression model.
CONCLUSION: The risk of stroke increased gradually by increasing age, and we could not detect any threshold concerning risk of stroke by age. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17409772     DOI: 10.1159/000101509

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  5 in total

Review 1.  Lone AF - Etiologic Factors and Genetic Insights into Pathophysiolgy.

Authors:  Babar Parvez; Dawood Darbar
Journal:  J Atr Fibrillation       Date:  2010-06-01

2.  Inducing stroke in aged, hypertensive, diabetic rats.

Authors:  Sarah S J Rewell; John A Fernandez; Susan F Cox; Neil J Spratt; Lisa Hogan; Elena Aleksoska; Leena van Raay; Gabriel T Liberatore; Peter E Batchelor; David W Howells
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-13       Impact factor: 6.200

Review 3.  Practical Issues to Prevent Stroke Associated with Non-valvular Atrial Fibrillation.

Authors:  Chi Kyung Kim; Seunguk Jung; Byung-Woo Yoon
Journal:  J Stroke       Date:  2013-09-27       Impact factor: 6.967

4.  Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium.

Authors:  Bente Morseth; Bastiaan Geelhoed; Allan Linneberg; Lars Johansson; Kari Kuulasmaa; Veikko Salomaa; Licia Iacoviello; Simona Costanzo; Stefan Söderberg; Teemu J Niiranen; Julie K K Vishram-Nielsen; Inger Njølstad; Tom Wilsgaard; Ellisiv B Mathiesen; Maja-Lisa Løchen; Tanja Zeller; Stefan Blankenberg; Francisco M Ojeda; Renate B Schnabel
Journal:  Open Heart       Date:  2021-07

5.  Effect of catheter ablation on clinical outcomes in patients with atrial fibrillation and significant functional mitral regurgitation.

Authors:  Jin-Tao Wu; Dan-Qing Zhao; Fu-Tao Zhang; Xiao-Jie Liu; Juan Hu; Lei-Ming Zhang; Xian-Wei Fan; Hai-Tao Yang; Li-Jie Yan; Jing-Jing Liu; Shan-Ling Wang
Journal:  BMC Cardiovasc Disord       Date:  2021-12-07       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.